Summary of Purpose
To compare the safety and efficacy of an oral direct thrombin inhibitor (ximelagatran) with those of warfarin (coumadin) in preventing stroke and systemic embolic events in patients with atrial fibrillation.Read More →
The following dates are available for this trial. Trial information last updated on 4 September 2008.
|Start Date||First Received||1st Completion||Completion||Verification||Results|
Randomized, open-label, parallel-group study, double blind, double-dummy treatment allocation and computerized algorithms to generate sham INR data.